Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.

Saved in:
Bibliographic Details
Title: Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.
Authors: Baharvand F; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Di Muro FM; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mohammadi A; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Aghajankhah M; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Parvaneh S; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Parsa NA; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Hassanipour S; Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran., Aboutaleb E; Department of Pharmaceutics, School of pharmacy, Guilan University of Medical Sciences, Rasht, Iran., Jenab Y; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. yasjenab@gmail.com., Aliabadi SB; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran.
Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 Jul 17. Date of Electronic Publication: 2026 Jul 17.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-187X
DOI:10.1007/s40256-026-00814-8